↓ Skip to main content
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Readers on

mendeley
163 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
Published in
Lancet Oncology, December 2012
DOI 10.1016/s1470-2045(12)70572-7
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United Kingdom 2 1%
United States 1 <1%
France 1 <1%
Unknown 159 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 30 18%
Researcher 24 15%
Other 15 9%
Student > Bachelor 12 7%
Student > Master 11 7%
Other 26 16%
Unknown 45 28%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 58 36%
Biochemistry, Genetics and Molecular Biology 21 13%
Agricultural and Biological Sciences 19 12%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Nursing and Health Professions 3 2%
Other 6 4%
Unknown 49 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 March 2022.
All research outputs
#1,228,633
of 34,763,505 outputs
Outputs from Lancet Oncology
#1,562
of 8,039 outputs
Outputs of similar age
#8,500
of 351,453 outputs
Outputs of similar age from Lancet Oncology
#11
of 95 outputs
Altmetric has tracked 34,763,505 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,039 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 39.1. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.